202 related articles for article (PubMed ID: 34811739)
1. Structural and molecular determinants of mineralocorticoid receptor signalling.
Grossmann C; Almeida-Prieto B; Nolze A; Alvarez de la Rosa D
Br J Pharmacol; 2022 Jul; 179(13):3103-3118. PubMed ID: 34811739
[TBL] [Abstract][Full Text] [Related]
2. Brain mineralocorticoid receptor in health and disease: From molecular signalling to cognitive and emotional function.
Paul SN; Wingenfeld K; Otte C; Meijer OC
Br J Pharmacol; 2022 Jul; 179(13):3205-3219. PubMed ID: 35297038
[TBL] [Abstract][Full Text] [Related]
3. Approaches towards tissue-selective pharmacology of the mineralocorticoid receptor.
Clarisse D; Deng L; de Bosscher K; Lother A
Br J Pharmacol; 2022 Jul; 179(13):3235-3249. PubMed ID: 34698367
[TBL] [Abstract][Full Text] [Related]
4. The mineralocorticoid receptor in skin disease.
Pérez P
Br J Pharmacol; 2022 Jul; 179(13):3178-3189. PubMed ID: 34788475
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptors in non-alcoholic fatty liver disease.
Schreier B; Zipprich A; Uhlenhaut H; Gekle M
Br J Pharmacol; 2022 Jul; 179(13):3165-3177. PubMed ID: 34935140
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor in cardiovascular diseases-Clinical trials and mechanistic insights.
Bauersachs J; López-Andrés N
Br J Pharmacol; 2022 Jul; 179(13):3119-3134. PubMed ID: 34643952
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid pathway in retinal health and diseases.
Behar-Cohen F; Zhao M
Br J Pharmacol; 2022 Jul; 179(13):3190-3204. PubMed ID: 34877649
[TBL] [Abstract][Full Text] [Related]
8. The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.
van der Heijden CDCC; Bode M; Riksen NP; Wenzel UO
Br J Pharmacol; 2022 Jul; 179(13):3135-3151. PubMed ID: 34935128
[TBL] [Abstract][Full Text] [Related]
9. The mineralocorticoid receptor in chronic kidney disease.
Barrera-Chimal J; Jaisser F; Anders HJ
Br J Pharmacol; 2022 Jul; 179(13):3152-3164. PubMed ID: 34786690
[TBL] [Abstract][Full Text] [Related]
10. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
Baker ME; Funder JW; Kattoula SR
J Steroid Biochem Mol Biol; 2013 Sep; 137():57-70. PubMed ID: 23907018
[TBL] [Abstract][Full Text] [Related]
11. Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease.
Parker BM; Wertz SL; Pollard CM; Desimine VL; Maning J; McCrink KA; Lymperopoulos A
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486399
[TBL] [Abstract][Full Text] [Related]
12. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
Sevilla LM; Pérez P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
[TBL] [Abstract][Full Text] [Related]
13. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling: DEPENDENCE ON DNA SEQUENCE, MR CONFORMATION, AND AP-1 FAMILY MEMBER EXPRESSION.
Dougherty EJ; Elinoff JM; Ferreyra GA; Hou A; Cai R; Sun J; Blaine KP; Wang S; Danner RL
J Biol Chem; 2016 Nov; 291(45):23628-23644. PubMed ID: 27650495
[TBL] [Abstract][Full Text] [Related]
15. Structure-function relationships of the aldosterone receptor.
Fuller PJ; Young MJ; Yang J; Cole TJ
Vitam Horm; 2023; 123():285-312. PubMed ID: 37717989
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators.
Meinel S; Gekle M; Grossmann C
Steroids; 2014 Dec; 91():3-10. PubMed ID: 24928729
[TBL] [Abstract][Full Text] [Related]
17. Towards selectively modulating mineralocorticoid receptor function: lessons from other systems.
Baxter JD; Funder JW; Apriletti JW; Webb P
Mol Cell Endocrinol; 2004 Mar; 217(1-2):151-65. PubMed ID: 15134814
[TBL] [Abstract][Full Text] [Related]
18. Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.
Kintscher U; Bakris GL; Kolkhof P
Br J Pharmacol; 2022 Jul; 179(13):3220-3234. PubMed ID: 34811750
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid receptor binding, structure and function.
Rogerson FM; Brennan FE; Fuller PJ
Mol Cell Endocrinol; 2004 Mar; 217(1-2):203-12. PubMed ID: 15134819
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid regulation of cell function: the role of rapid signalling and gene transcription pathways.
Ong GS; Young MJ
J Mol Endocrinol; 2017 Jan; 58(1):R33-R57. PubMed ID: 27821439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
